ARTCLINE
Artcline is a biotechnology company that develops diagnostic and therapeutic procedures for intensive care medicine.
ARTCLINE
Industry:
Biotechnology Health Diagnostics Medical Therapeutics
Founded:
2007-01-01
Address:
Rostock, Mecklenburg-Vorpommern, Germany
Country:
Germany
Website Url:
http://www.artcline.de
Total Employee:
11+
Status:
Active
Contact:
+49 0 381 440 703 0
Email Addresses:
[email protected]
Total Funding:
4.4 M EUR
Technology used in webpage:
Euro German Server Location
Similar Organizations
Freeline
Freeline Therapeutics is a biotechnology company focused on developing liver directed gene therapies for a range of diseases.
Mestag Therapeutics
Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.
Monte Rosa Therapeutics
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
ReViral
ReViral is a biotechnology company that develops and offers antiviral therapies for patients.
Spectrawave
Spectrawave is a medical device company that develops optical diagnostic and therapeutic devices.
Telomium
Telomium is a biotechnology company developing a therapeutic product for cancer immunotherapy.
Current Employees Featured
Founder
Official Site Inspections
http://www.artcline.de
- Host name: www497.your-server.de
- IP address: 188.40.218.38
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Artcline"
ARTCLINE – BIO-THERAPIES
ARTCLINE BIO-THERAPIES ARTCLINE develops innovative diagnostic and therapeutic procedures for intensive care medicine. Learn moreSee details»
About - ARTCLINE
ARTCLINE‘s vision is to become the leading biotech company for immune cell based extracorporeal sepsis therapy. Currently, we are focused on the clinical trials and the further development of our ARTICE® Therapy for the treatment …See details»
Artcline - Crunchbase Company Profile & Funding
Artcline is a biotechnology company that develops diagnostic and therapeutic procedures for intensive care medicine. Legal Name Artcline GmbH. A …See details»
Contact – ARTCLINE
Address: ARTCLINE GmbH Schillingallee 68 18057 Rostock Germany. E-Mail: [email protected]. Phone: +49 (0)381 440 703 0. Fax: +49 (0)381 440 703 29See details»
ARTCLINE GmbH - LinkedIn
ARTCLINE GmbH develops innovative therapy methods for intensive care medicine based on immune cells. Our current main project is the development of the so-called ARTICE technology for the...See details»
ARTCLINE Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for ARTCLINE. Use the PitchBook Platform to explore the full profile.See details»
ArtCline - Overview, News & Similar companies | ZoomInfo.com
Mar 25, 2024 · View ArtCline (www.artcline.de) location in Mecklenburg-Vorpommern, Germany , revenue, industry and description. Find related and similar companies as well as employees …See details»
Artcline - VentureRadar
"Artcline is a healthcare company specializing in developing novel immune cell-based extracorporeal sepsis therapy. Founded as a spin-off from the University of Rostock, the …See details»
ARTCLINE - Company Profile - Tracxn
Nov 2, 2024 · ARTCLINE - Developer of immune-cell therapy system for sepsis treatment. Raised a total funding of $4.75M over 1 round. Founded by Jens Altrichter and Steffen Mitzner in the …See details»
ARTCLINE successfully completes capital increases of EUR 4.4 million
Mar 25, 2024 · Today ARTCLINE GmbH announced the successful completion of two further capital increases. In addition to the founders, in particular family offices from Germany …See details»
ArtCline Company Profile | Management and Employees List
ArtCline Profile and History. ARTCLINE GmbH has been a spin-off from the University of Rostock since 2007. The aim of ARTCLINE is to develop innovative therapeutic and diagnostic …See details»
Artcline Raises EUR4.4M in Funding - finsmes.com
Mar 25, 2024 · Artcline, a Rostock, a Germany-based company advancing novel immune cell-based extracorporeal sepsis therapy, raised EUR4.4M in funding. In addition to the founders, …See details»
ARTCLINE - Products, Competitors, Financials, Employees, …
ARTCLINE specializes in the development of diagnostic and therapeutic procedures for intensive care medicine, particularly focusing on immune cell-based therapies. Use the CB Insights …See details»
ARTCLINE successfully completes capital increases of EUR 4.4 million
Mar 25, 2024 · Today ARTCLINE GmbH announced the successful completion of two further capital increases. In addition to the founders, in particular family offices from Germany …See details»
Jens Altrichter - CEO, Founder and Managing Director @ Artcline ...
Jens Altrichter is the Founder and CEO of Artcline. He previously worked at LEUKOCARE AG as a COO. Jens Altrichter attended the University of Rostock.See details»
News – ARTCLINE
USPTO grants to ARTCLINE the US patent for a “METHOD FOR PRODUCING A LEUKOCYTE PREPARATION” 13th August 2019 ARTCLINE receives innovation grant from the BMBF for …See details»
Artcline Company Information - Funding, Investors, and More
Immune cell-based extracorporeal sepsis therapy developer. GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY. Get information on funding, investors, …See details»
ARTCLINE GmbH: ARTCLINE erhält weitere 4 Mio. Euro und startet ...
Die 2007 in Rostock gegründete ARTCLINE GmbH entwickelt innovative Therapieverfahren für die Intensivmedizin. Der Fokus liegt in der Entwicklung von Immunzell-basierten Therapien zur …See details»
Solution – ARTCLINE
ARTCLINE provides a functional sepsis therapy by combining the two worlds of blood products and extracorporeal devicesSee details»
ARTCLINE successfully completes capital increases of EUR
Mar 25, 2024 · Morningstar brands and products Company Get 7 Days FreeSee details»